- Home
- SSRM vs APGE Comparison
SSRM vs APGE Comparison
Compare SSRM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSRM | APGE |
|---|---|---|
| Founded | 1946 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.5B |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SSRM | APGE |
|---|---|---|
| Price | $28.15 | $68.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $26.11 | ★ $103.33 |
| AVG Volume (30 Days) | ★ 4.3M | 1.1M |
| Earning Date | 02-17-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $1,431,099,000.00 | N/A |
| Revenue This Year | $58.39 | N/A |
| Revenue Next Year | $56.37 | N/A |
| P/E Ratio | $25.97 | ★ N/A |
| Revenue Growth | ★ 30.30 | N/A |
| 52 Week Low | $8.65 | $26.20 |
| 52 Week High | $28.81 | $84.56 |
Technical Indicators
Market Signals| Indicator | SSRM | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 50.94 |
| Support Level | $25.91 | $60.35 |
| Resistance Level | $27.78 | $66.18 |
| Average True Range (ATR) | 1.60 | 4.02 |
| MACD | 0.09 | 0.20 |
| Stochastic Oscillator | 61.42 | 77.58 |
Price Performance
Historical ComparisonAbout SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.